Corda Investment Management, Llc. Organon & Co. Transaction History

Corda Investment Management, Llc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$19.27 - $24.63 $310,748 - $397,183	-16,126 Reduced 9.51%	153,466 $3.19 Million
Q1 2023 May 04, 2023	SELL	$21.42 - $32.08 $502,684 - $752,853	-23,468 Reduced 12.16%	169,592 $3.99 Million
Q4 2022 Feb 06, 2023	SELL	$23.31 - $28.61 $1.22 Million - $1.49 Million	-52,229 Reduced 21.29%	193,060 $5.39 Million
Q3 2022 Nov 09, 2022	SELL	$23.4 - $34.25 $2.29 Million - $3.36 Million	-98,017 Reduced 28.55%	245,289 $5.74 Million
Q2 2022 Aug 10, 2022	SELL	$31.66 - $38.9 $1.13 Million - $1.39 Million	-35,734 Reduced 9.43%	343,306 $11.6 Million
Q1 2022 May 10, 2022	BUY	$30.45 - $39.36 $733,997 - $948,772	24,105 Added 6.79%	379,040 $13.2 Million
Q4 2021 Feb 08, 2022	BUY	$28.67 - $37.13 $1.19 Million - $1.54 Million	41,544 Added 13.26%	354,935 $10.8 Million
Q3 2021 Nov 15, 2021	BUY	$28.63 - $35.64 $7.21 Million - $8.97 Million	251,665 Added 407.71%	313,391 $10.3 Million
Q2 2021 Aug 11, 2021	BUY	$28.45 - $38.0 $1.76 Million - $2.35 Million	61,726 New	61,726 $1.87 Million

786

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.04B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Corda Investment Management, Llc., based on Form 13F filings with the SEC.

Stay updated on Corda Investment Management, Llc. with notifications on news.